These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28733173)

  • 1. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
    Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
    J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
    Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia.
    Noto D; Cefalù AB; Valenti V; Fayer F; Pinotti E; Ditta M; Spina R; Vigna G; Yue P; Kathiresan S; Tarugi P; Averna MR
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):805-9. PubMed ID: 22247256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.
    Minicocci I; Santini S; Cantisani V; Stitziel N; Kathiresan S; Arroyo JA; Martí G; Pisciotta L; Noto D; Cefalù AB; Maranghi M; Labbadia G; Pigna G; Pannozzo F; Ceci F; Ciociola E; Bertolini S; Calandra S; Tarugi P; Averna M; Arca M
    J Lipid Res; 2013 Dec; 54(12):3481-90. PubMed ID: 24058201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
    Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
    Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.
    Minicocci I; Tikka A; Poggiogalle E; Metso J; Montali A; Ceci F; Labbadia G; Fontana M; Di Costanzo A; Maranghi M; Rosano A; Ehnholm C; Donini LM; Jauhiainen M; Arca M
    J Lipid Res; 2016 Jun; 57(6):1097-107. PubMed ID: 27040449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation.
    Martín-Campos JM; Roig R; Mayoral C; Martinez S; Martí G; Arroyo JA; Julve J; Blanco-Vaca F
    Clin Chim Acta; 2012 Mar; 413(5-6):552-5. PubMed ID: 22155345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
    Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
    Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis.
    Ossoli A; Minicocci I; Turri M; Di Costanzo A; D'Erasmo L; Bini S; Montavoci L; Veglia F; Calabresi L; Arca M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159263. PubMed ID: 36521735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
    Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.
    Minicocci I; Montali A; Robciuc MR; Quagliarini F; Censi V; Labbadia G; Gabiati C; Pigna G; Sepe ML; Pannozzo F; Lütjohann D; Fazio S; Jauhiainen M; Ehnholm C; Arca M
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1266-75. PubMed ID: 22659251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene.
    Martín-Morales R; García-Díaz JD; Tarugi P; González-Santos P; Saavedra-Vallejo P; Magnolo L; Mesa-Latorre JM; di Leo E; Valdivielso P
    Gene; 2013 Nov; 531(1):92-6. PubMed ID: 24001780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.
    Noto D; Arca M; Tarugi P; Cefalù AB; Barbagallo CM; Averna MR
    Acta Diabetol; 2017 Feb; 54(2):111-122. PubMed ID: 27804036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ANGPTL3 in controlling lipoprotein metabolism.
    Tikka A; Jauhiainen M
    Endocrine; 2016 May; 52(2):187-93. PubMed ID: 26754661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypobetalipoproteinemia and abetalipoproteinemia.
    Welty FK
    Curr Opin Lipidol; 2014 Jun; 25(3):161-8. PubMed ID: 24751931
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.